Choosing the right cell line for breast cancer research

Deborah L Holliday, Valerie Speirs (Corresponding Author)

Research output: Contribution to journalReview articlepeer-review

1032 Citations (Scopus)
5 Downloads (Pure)


Breast cancer is a complex and heterogeneous disease. Gene expression profiling has contributed significantly to our understanding of this heterogeneity at a molecular level, refining taxonomy based on simple measures such as histological type, tumour grade, lymph node status and the presence of predictive markers like oestrogen receptor and human epidermal growth factor receptor 2 (HER2) to a more sophisticated classification comprising luminal A, luminal B, basal-like, HER2-positive and normal subgroups. In the laboratory, breast cancer is often modelled using established cell lines. In the present review we discuss some of the issues surrounding the use of breast cancer cell lines as experimental models, in light of these revised clinical classifications, and put forward suggestions for improving their use in translational breast cancer research.

Original languageEnglish
Article number215
JournalBreast Cancer Research
Publication statusPublished - 12 Aug 2011


  • Animals
  • Breast Neoplasms
  • Cell Line, Tumor
  • Estrogen Receptor alpha
  • Female
  • Humans
  • Mice
  • Neoplastic Stem Cells
  • Receptor, ErbB-2
  • Receptors, Progesterone
  • Research Design
  • Xenograft Model Antitumor Assays
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review


Dive into the research topics of 'Choosing the right cell line for breast cancer research'. Together they form a unique fingerprint.

Cite this